Ejal 40 is an injectable biorevitalisant developed for prolonged skin hydration and tissue bio-modulation. The formulation contains a unique combination of two high-molecular-weight fractions of non-crosslinked hyaluronic acid, designed to distribute evenly within the dermal structures and integrate efficiently into skin metabolism.
The product is manufactured using the proprietary RDP (Reological Degradation Process) technology, which is designed to enhance biocompatibility and improve the stability of non-crosslinked hyaluronic acid while maintaining its physiological behaviour.
Due to its molecular structure, the hyaluronic acid in Ejal 40 is intended to:
- bind and retain water within the dermal matrix, supporting long-lasting hydration;
- interact with skin cell receptors involved in extracellular matrix maintenance;
- contribute to protection against oxidative stress;
- support tissue trophism and cellular metabolism;
- demonstrate increased resistance to enzymatic degradation compared to conventional non-stabilised hyaluronic acid.
The absence of chemical crosslinking allows the product to integrate gently into the tissue, without adding volume or structural rigidity. Thanks to its low viscosity and high biocompatibility, Ejal 40 is designed for physiological skin support without heaviness or prolonged downtime.
When administered by qualified healthcare professionals, Ejal 40 is intended to support:
- intensive and sustained skin hydration
- improvement of skin elasticity and firmness
- optimisation of skin texture and dermal density
- reduction in the appearance of superficial skin irregularities
The product may be used as part of aesthetic treatment protocols in cases of:
- early to moderate signs of intrinsic and extrinsic skin ageing
- dehydrated or loss-of-tone skin
- dull or uneven skin appearance
- supportive care in pigmentation-related concerns (as part of combination therapy)
- scars and stretch marks
- pre- and post-procedural skin conditioning (e.g. laser, peeling, energy-based treatments)
Typical treatment areas include the face, neck, décolleté and hands.
Individual results and treatment duration depend on patient condition, technique, and treatment plan.
Each package of Ejal 40 contains:
• Hyaluronic Acid – 20 mg (1000 kDa)
• Hyaluronic Acid – 20 mg (1500 kDa)
Non-crosslinked, high-molecular-weight hyaluronic acid fractions.
• Physiological buffer solution
• Package contents:
1 sterile pre-filled syringe with 2 ml of solution.
The product is intended for injection into the mid to deep dermis using linear-retrograde techniques, including the manufacturer’s recommended 4-point protocol.
Needles or cannulas are not included.
Important Notice:
Ejal 40 is a CE-marked medical device intended exclusively for professional use.
Administration must be performed only by qualified and certified healthcare professionals in accordance with the official instructions for use.
This product description is provided for informational purposes only and does not replace medical training or professional judgment.